Intermittently-scanned CGM is associated with lower HbA1c and reduced hospital admissions for adults with type 2 diabetes on insulin therapy in Sweden: a retrospective controlled study

被引：0
|
作者：
Nathanson, D. [1 ]
Eeg-Olofsson, K. [2 ]
Spelman, T. [3 ]
Bulow, E. [4 ]
Kyhlstedt, M. [3 ]
Levrat-Guillen, F. [5 ]
Bolinder, J. [1 ]
机构：
[1] Karolinska Univ Hosp Huddinge, Dept Med, Stockholm, Sweden
[2] Sahlgrens Univ Hosp, Dept Mol & Clin Med, Gothenburg, Sweden
[3] Synergus RWE AB, Akersberga, Sweden
[4] Registercentrum, Vastra Gotaland, Sweden
[5] Abbott Labs Ltd, Maidenhead, Berks, England
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
821
引用
收藏
页码：S422 / S422
页数：1
相关论文
共 50 条
  • [31] Sustainable HbA1c Decrease at 12 Months for Adults with Type 1 and Type 2 Diabetes Using the FreeStyle Libre System: A Study within the National Diabetes Register in Sweden
    Eeg-Olofsson, Katarina
    Svensson, Ann-Marie
    Franzen, Stefan
    Ismail, Hodan
    Levrat-Guillen, Fleur
    DIABETES, 2020, 69
  • [32] Type 2 diabetes and HbA1c are independently associated with wider retinal arterioles: the Maastricht study
    Li, Wenjie
    Schram, Miranda T.
    Berendschot, Tos T. J. M.
    Webers, Carroll A. B.
    Kroon, Abraham A.
    van der Kallen, Carla J. H.
    Henry, Ronald M. A.
    Schaper, Nicolaas C.
    Huang, Fan
    Dashtbozorg, Behdad
    Tan, Tao
    Zhang, Jiong
    Abbasi-Sureshjani, Samaneh
    Romeny, Bart M. Ter Haar
    Stehouwer, Coen D. A.
    Houben, Alfons J. H. M.
    DIABETOLOGIA, 2020, 63 (07) : 1408 - 1417
  • [33] EXCESSIVE DAYTIME SLEEPINESS IS ASSOCIATED WITH HIGHER HBA1C IN TYPE 2 DIABETES: THE GLYCOSA STUDY
    Aurora, R. N.
    Shaw, J.
    Fulcher, G.
    Naughton, M.
    Cistulli, P. A.
    Bergenstal, R. M.
    Punjabi, N. M.
    SLEEP, 2011, 34 : A222 - A222
  • [34] Type 2 diabetes and HbA1c are independently associated with wider retinal arterioles: the Maastricht study
    Wenjie Li
    Miranda T. Schram
    Tos T. J. M. Berendschot
    Carroll A. B. Webers
    Abraham A. Kroon
    Carla J. H. van der Kallen
    Ronald M. A. Henry
    Nicolaas C. Schaper
    Fan Huang
    Behdad Dashtbozorg
    Tao Tan
    Jiong Zhang
    Samaneh Abbasi-Sureshjani
    Bart M. ter Haar Romeny
    Coen D. A. Stehouwer
    Alfons J. H. M. Houben
    Diabetologia, 2020, 63 : 1408 - 1417
  • [35] Impact of an Acceptance and Commitment Therapy programme on HbA1c, self-management and psychosocial factors in adults with type 1 diabetes and elevated HbA1c levels: a randomised controlled trial
    Wijk, Ingrid
    Amsberg, Susanne
    Johansson, Unn-Britt
    Livheim, Fredrik
    Toft, Eva
    Anderbro, Therese
    BMJ OPEN, 2023, 13 (12):
  • [36] C-peptide persistence is associated with lower HbA1c, higher time in range and low rates of hypoglycaemia in adults with type 1 diabetes
    Gibb, F. W.
    Dover, A. R.
    Jeeyavudeen, M. S.
    Wright, R.
    Forbes, S.
    Lyall, M. J.
    Stimson, R. H.
    Strachan, M. W.
    DIABETOLOGIA, 2024, 67 : S123 - S124
  • [37] What are the HbA1c thresholds for initiating insulin therapy in people with type 2 diabetes in UK primary care?
    Hinton, W.
    McGovern, A. P.
    Whyte, M.
    Curtis, B. H.
    McCullough, K.
    van Brunt, K.
    Calderara, S.
    de Lusignan, S.
    DIABETOLOGIA, 2016, 59 : S416 - S417
  • [38] Physiologic hormone administration improves HbA1C in Native Americans with type 2 diabetes: A retrospective study and review of insulin secretion and action
    Rebello, Candida J.
    Morales, Tyler S.
    Chuon, Katsya
    Dong, Shu
    Lam, V. Tyrone
    Purner, Dan
    Lewis, Stanley
    Lakey, Jonathan
    Beyl, Robbie A.
    Greenway, Frank L.
    OBESITY REVIEWS, 2023, 24 (12)
  • [39] High HbA1c Levels Are Associated With Development of Trigger Finger in Type 1 and Type 2 Diabetes: An Observational Register-Based Study From Sweden
    Rydberg, Mattias
    Zimmerman, Malin
    Gottsater, Anders
    Eeg-Olofsson, Katarina
    Dahlin, Lars B.
    DIABETES CARE, 2022, 45 (11) : 2669 - 2674
  • [40] Reduced risk of hypoglycaemia and lower HbA1c with degludec compared to glargine U300 in insulin-treated patients with type 2 diabetes
    Philis-Tsimikas, A.
    Klonoff, D. C.
    Khunti, K.
    Bajaj, H. S.
    Leiter, L. A.
    Tutkunkardas, D.
    Troelsen, L. Norgard
    Bak, B. A.
    Heller, S. R.
    Pieber, T. R.
    DIABETOLOGIA, 2019, 62 : S47 - S47
12345